Company Info
| Phone: | (203) 406-3700 |
| Year Established: | 2004 |
| Ticker: | CARA |
| Exchange: | NASDAQ |
Contacts
| Primary: | Christopher Posner President & CEO |
| Other: | Joana Goncalves, M.D. CMO Scott Terrillion General Counsel Ryan Maynard CFO |
Company Description
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.
